$17.57
-1.42-7.48%
Last update: Nov 5, 5:33 PM
Sarepta Therapeutics Inc
SRPTNASDAQ
The average analyst price target for Sarepta Therapeutics is $24.52, 43.4% above the current price. Of 24 analysts, 9 rate it Buy, 10 Hold and 5 Sell. Targets range from $5 to $80. The latest change came on Oct 8, 2026, when RBC Capital lowered its price target on Sarepta Therapeutics from $19 to $17 and kept a Sector Perform rating.
Price Target Range — 7 Quarters
Analyst Consensus — 24 Analysts
Rating Trend — Last 9 Months
